Study Evaluating Bazedoxifene Dose-Response in Japanese Patients With Postmenopausal Osteoporosis.

NCT00238745 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

375

Enrollment

INDUSTRY

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: Bazedoxifene
DRUG: Placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer